LUMENA PHARMACEUTICALS INC has a total of 53 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2012. It filed its patents most often in United States, Mexico and Republic of Korea. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and environmental technology are LUMENA PHARMACEUTICALS LLC, GLADE ORGANICS PRIVATE LTD and CHANGZHOU DEZE MEDICAL SCIENCE CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 9 | |
#2 | Mexico | 7 | |
#3 | Republic of Korea | 6 | |
#4 | Singapore | 6 | |
#5 | WIPO (World Intellectual Property Organization) | 6 | |
#6 | Canada | 5 | |
#7 | China | 4 | |
#8 | EPO (European Patent Office) | 4 | |
#9 | Brazil | 2 | |
#10 | Israel | 2 | |
#11 | South Africa | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Gedulin Bronislava | 44 |
#2 | Grey Michael | 39 |
#3 | O'Donnell Niall | 38 |
#4 | Keller Bradley T | 14 |
#5 | Bronislava Gedulin | 7 |
#6 | Michael Grey | 7 |
#7 | Niall O'Donnell | 4 |
#8 | Bradley T Keller | 2 |
#9 | Niall O'Donell | 2 |
#10 | Niall O`Donnell | 1 |
Publication | Filing date | Title |
---|---|---|
WO2015065983A1 | Bile acid recycling inhibitors for treatment of gastrointestinal infections | |
MX2015013196A | Bile acid recycling inhibitors for treatment of barrett's esophagus and gastroesophageal reflux disease. | |
MX2015013193A | Bile acid recycling inhibitors for treatment of primary sclerosing cholangitis and inflammatory bowel disease. | |
MX369466B | Bile acid recycling inhibitors for treatment of pediatric cholestatic liver diseases. | |
WO2013020108A2 | Bile acid recycling inhibitors for treatment of pancreatitis |